Absci Corp is the Artificial intelligence powered synthetic biology company unlocking the potential of proteins as the next generation of therapeutics. It enables the creation of novel biologics by unifying biologic drug discovery and cell line development into one simultaneous process.

$333.1M

Market Cap • 3/13/2025

2011

(14 years)

Founded

2021

(4 years ago)

IPO

NASDAQ

Listing Exchange

Flag of US

Vancouver

Headquarters • Washington